While a fragile ceasefire remains in place, hundreds of thousands of Palestinians are living in makeshift tents after two ...

What is the outlook for someone who has squamous cell carcinoma of the skin? The outlook is excellent when found early and properly treated. More than 90% of patients are cured. FDA-approved ...

The deal brings Dark Blue's preclinical oncology products, including an MLLT1/3-targeted agent for leukemias, into Amgen's portfolio.

ELF3 axis enables luminal progenitor transformation in BRCA1-deficient breast cancer by reducing genomic instability and promoting progenitor identity.

In what is thought to be the first major pharma M&A deal of the year, Amgen has bought Oxford, UK-based biotech Dark Blue ...

Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors. The company said its Smart Basal ...

Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers. * Dexcom Smart Basal is FDA cleared and now the ...

From the Civil War to the dawn of the new millennium, one book has held a secure spot in American classrooms: the basal reader. These anthologies of excerpts, poems, and other short works have been ...

Dermatologist reviewed: Natalie Matthews, MD, MPhil, FAAD; Rajiv I. Nijhawan, MD, FACMS, FAAD; and Darrell S. Rigel, MD, FAAD. Reviewer bios. What is the outcome for a person who has basal cell ...

ABSTRACT: Introduction: Hypersensitivity of the skin of PWA to ultraviolet rays, resulting from insufficient melanin production, exposes them to precancerous and cancerous lesions. The head is highly ...

1. In patients with type 2 diabetes mellitus (T2DM) who had not previously been on insulin therapy, once-weekly fixed-dose insulin efsitora was noninferior to daily insulin glargine in reducing ...